Scopus Biopharma Price History
If you're considering investing in Scopus OTC Stock, it is important to understand the factors that can impact its price. We have found zero technical indicators for Scopus Biopharma, which you can use to evaluate the volatility of the company.
Scopus OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Scopus |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
SCPS |
Based on monthly moving average Scopus Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Scopus Biopharma by adding Scopus Biopharma to a well-diversified portfolio.
Scopus Biopharma OTC Stock Price History Chart
There are several ways to analyze Scopus Stock price data. The simplest method is using a basic Scopus candlestick price chart, which shows Scopus Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
No Historical data is available at this time
CFMDIVO | 1.62 | ||||
MXX | 1.27 | ||||
HNX 30 | 1.15 | ||||
PX | 1.01 | ||||
Tel Aviv | 0.89 | ||||
KLTE | 0.79 | ||||
XELKT | 0.75 | ||||
Budapest | 0.54 | ||||
APACXJ | 0.44 | ||||
IDX 30 | 0.42 | ||||
WIG 30 | 0.36 | ||||
IMAT | 0.20 | ||||
PSI 20 | 0.18 | ||||
AXDI | 0.10 | ||||
BETNG | 0.07 | ||||
MERV | 0.00 | ||||
ATG | 0.03 | ||||
IBEX 35 | 0.07 | ||||
SET | 0.21 | ||||
NYA | 0.26 | ||||
CROBEX | 0.29 | ||||
ATX | 0.33 | ||||
PSEI | 0.43 | ||||
OSEFX | 0.59 | ||||
GDAXI | 0.70 | ||||
ISEQ 20 | 0.77 | ||||
SLI | 0.81 | ||||
ASCX | 0.82 | ||||
BELS | 1.19 | ||||
TWII | 1.39 |
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Scopus OTC Stock
If you are still planning to invest in Scopus Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scopus Biopharma's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |